TY - JOUR
T1 - Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity
AU - Douglass, Stephen M.
AU - Fane, Mitchell E.
AU - Sanseviero, Emilio
AU - Ecker, Brett L.
AU - Kugel, Curtis H.
AU - Behera, Reeti
AU - Kumar, Vinit
AU - Tcyganov, Evgenii N.
AU - Yin, Xiangfan
AU - Liu, Qin
AU - Chhabra, Yash
AU - Alicea, Gretchen M.
AU - Kuruvilla, Rejji
AU - Gabrilovich, Dmitry I.
AU - Weeraratna, Ashani T.
N1 - Publisher Copyright:
©2020 American Association for Cancer Research.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Metastatic dissemination remains a significant barrier to successful therapy for melanoma. Wnt5A is a potent driver of invasion in melanoma and is believed to be secreted from the tumor microenvironment (TME). Our data suggest that myeloid-derived suppressor cells (MDSC) in the TME are a major source of Wnt5A and are reliant upon Wnt5A for multiple actions. Knockdown of Wnt5A specifically in the myeloid cells demonstrated a clear decrease in Wnt5A expression within the TME in vivo as well as a decrease in intratumoral MDSC and regulatory T cell (Treg). Wnt5A knockdown also decreased the immunosuppressive nature of MDSC and decreased expression of TGFb1 and arginase 1. In the presence of Wnt5A-depleted MDSC, tumor-infiltrating lymphocytes expressed decreased PD-1 and LAG3, suggesting a less exhausted phenotype. Myeloid-specific Wnt5A knockdown also led to decreased lung metastasis. Tumor-infiltrating MDSC from control animals showed a strong positive correlation with Treg, which was completely ablated in animals with Wnt5Anegative MDSC. Overall, our data suggest that while MDSC contribute to an immunosuppressive and less immunogenic environment, they exhibit an additional function as the major source of Wnt5A in the TME. Significance: These findings demonstrate that myeloid cells provide a major source of Wnt5A to facilitate metastatic potential in melanoma cells and rely on Wnt5A for their immunosuppressive function.
AB - Metastatic dissemination remains a significant barrier to successful therapy for melanoma. Wnt5A is a potent driver of invasion in melanoma and is believed to be secreted from the tumor microenvironment (TME). Our data suggest that myeloid-derived suppressor cells (MDSC) in the TME are a major source of Wnt5A and are reliant upon Wnt5A for multiple actions. Knockdown of Wnt5A specifically in the myeloid cells demonstrated a clear decrease in Wnt5A expression within the TME in vivo as well as a decrease in intratumoral MDSC and regulatory T cell (Treg). Wnt5A knockdown also decreased the immunosuppressive nature of MDSC and decreased expression of TGFb1 and arginase 1. In the presence of Wnt5A-depleted MDSC, tumor-infiltrating lymphocytes expressed decreased PD-1 and LAG3, suggesting a less exhausted phenotype. Myeloid-specific Wnt5A knockdown also led to decreased lung metastasis. Tumor-infiltrating MDSC from control animals showed a strong positive correlation with Treg, which was completely ablated in animals with Wnt5Anegative MDSC. Overall, our data suggest that while MDSC contribute to an immunosuppressive and less immunogenic environment, they exhibit an additional function as the major source of Wnt5A in the TME. Significance: These findings demonstrate that myeloid cells provide a major source of Wnt5A to facilitate metastatic potential in melanoma cells and rely on Wnt5A for their immunosuppressive function.
KW - Animals
KW - Antigens, CD/metabolism
KW - Arginase/metabolism
KW - Cell Line, Tumor
KW - Female
KW - Lung Neoplasms/secondary
KW - Lymphocyte Activation Gene 3 Protein
KW - Lymphocytes, Tumor-Infiltrating/metabolism
KW - Male
KW - Melanoma/metabolism
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Transgenic
KW - Myeloid-Derived Suppressor Cells/immunology
KW - Neoplasm Invasiveness
KW - Programmed Cell Death 1 Receptor/metabolism
KW - T-Lymphocytes, Regulatory/metabolism
KW - Transforming Growth Factor beta1/metabolism
KW - Tumor Microenvironment
KW - Wnt-5a Protein/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85100391256&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000617319600014&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1158/0008-5472.CAN-20-1238
DO - 10.1158/0008-5472.CAN-20-1238
M3 - Article
C2 - 33262126
SN - 0008-5472
VL - 81
SP - 658
EP - 670
JO - Cancer Research
JF - Cancer Research
IS - 3
ER -